Cavalier, E.
Eastell, R.
Jørgensen, N. R.
Makris, K.
Tournis, S.
Vasikaran, S.
Kanis, J. A.
Cooper, C.
Pottel, H.
Morris, H. A.
,
Article History
Received: 10 December 2020
Accepted: 27 January 2021
First Online: 4 March 2021
Change Date: 17 April 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s00223-021-00839-y
Compliance with Ethical Standards
:
: EC is consultant for IDS, DiaSorin, Menarini, Nittobo, bioMérieux, and Fujirebio. RE has received grants and/or personal fees from Amgen, IDS, Alexion, Roche, GSK Nutrition, Mero, Sandoz, and Nittobo. HP, ST, SV, NRJ, JK, and KM have no conflict of interest.
: Approval by a Local Research Ethics Committee was obtained for each center with all participating patients signing an informed consent form.